Survival and analysis of predictors of mortality in patients undergoing replacement renal therapy: a 20-year cohort.

Emily de Souza FerreiraTiago Ricardo MoreiraRodrigo Gomes da SilvaGlauce Dias da CostaLuciana Saraiva da SilvaSamantha Bicalho de Oliveira CavalierBeatriz Oliveira SilvaHeloísa Helena DiasLuiza Delazari BorgesJuliana Costa MachadoRosângela Minardi Mitre Cotta

Published in: BMC nephrology (2020)

survival remains low in the early years of ESRD treatment. The present study identified that elevated values of ferritin, serum calcium, phosphorus, albumin, leukocyte, serum protein and serum iron values as a useful prognostic factor for the survival time.

Keyphrases

prognostic factors
patients undergoing
free survival
cardiovascular events
risk factors
mesenchymal stem cells
risk assessment
bone marrow
binding protein
chronic kidney disease
small molecule
cell therapy
protein protein
combination therapy
heavy metals